Suzhou, China

Jian Dai

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Coherent Biopharma I, Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Dai. Retrieved from https://idiyas.com/inventor/jian-dai-2cev31yk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jian Dai

Introduction

Jian Dai is a prominent inventor based in Suzhou, China. He has made significant strides in the field of pharmaceuticals, particularly with his innovative approach to drug conjugates. His work focuses on enhancing the efficacy of treatments through targeted delivery mechanisms.

Latest Patents

Jian Dai holds a patent for "Multi-ligand drug conjugates and uses thereof." This invention involves conjugate compounds or pharmaceutically acceptable salts that comprise a payload and two or more kinds of cell-interacting molecules. The cell-interacting molecules are ligands capable of specifically binding to a cell surface receptor. This method of treating diseases involves delivering a payload to a subject, showcasing his commitment to advancing medical science.

Career Highlights

Jian Dai is associated with Coherent Biopharma I, Limited, where he applies his expertise in drug development. His innovative contributions have positioned him as a key figure in the pharmaceutical industry, particularly in the realm of targeted therapies.

Collaborations

Jian Dai collaborates with notable colleagues, including Xinli Hu and Baohua Robert Huang. Their combined efforts contribute to the advancement of biopharmaceutical research and development.

Conclusion

Jian Dai's work exemplifies the intersection of innovation and healthcare, making significant contributions to the field of drug development. His patent on multi-ligand drug conjugates highlights his dedication to improving treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…